benign prostatic hyperplasia

(redirected from Prostatic hypertrophy)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for benign prostatic hyperplasia

enlarged prostate


Related Words

References in periodicals archive ?
The incidence of diverticula of urinary bladder in patients with benign prostatic hypertrophy and the comparison between cystoscopy and cystography in detecting bladder diverticula.
Clinical evaluation of Cernilton in benign prostatic hypertrophy.
The researchers excluded men whose serum concentrations of prostate specific antigen were more than 10 [micro]g/l and any who had recently taken drugs for benign prostatic hypertrophy.
Blue nevus is the commonest melanocytic lesion arising in the prostate that is usually an incidental finding on transurethral resection for benign prostatic hypertrophy or at autopsy.
This condition is known as benign prostatic hypertrophy (BPH) or an enlarged prostate gland.
Abbas explained that the most common of the prostatic problems is prostate gland enlargement -- in medical terms benign prostatic hyperplasia (BPH) or prostatic hypertrophy -- that affects older men.
Terazosin is an [alpha]-adrenergic blocker approved for the treatment of hypertension or of benign prostatic hypertrophy.
Terazosin is an [alpha] adrenergic blocker approved for the treatment of hypertension or of benign prostatic hypertrophy.
His surgical history included transurethral resection of the prostate (TURP) for benign prostatic hypertrophy, approximately 10 years prior to his current presentation.
1C] 19%), benign prostatic hypertrophy, hematuria (negative cystoscopy ten years prior) and dyslipidemia presented with a three day history of difficulty urinating, hematuria, fever, chills and low back pain.
Transurethral resection of the prostate (TURP) is performed to alleviate the symptoms of an enlarged prostate, a condition called benign prostatic hypertrophy (BPH).
2mg/ 4mg (silodosin), an agent for treating urination disorder associated with benign prostatic hypertrophy (BPH), on May 11.
Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate carcinoma and the relationship to endocrine therapy.
It was not very specific [as many as 25% of the patients with benign prostatic hypertrophy (BPH) gave values greater than 4.